Medication

Peptides for longevity: evidence, risks, and limits

Peptides for longevity: evidence, risks, and limits

What real support peptides have outside GLP 1 drugs, why regulation matters, and how to judge safety, efficacy, and black market risk.

Menopause without taboo: symptoms, hormones, self care

Menopause without taboo: symptoms, hormones, self care

Menopause is not silence or resignation. Learn how to identify symptoms, personalize hormone care, and recover physical, mental, and sexual wellbeing.

How to lower your A1c with data, habits, and tests

How to lower your A1c with data, habits, and tests

A practical approach to improve glucose and body composition using A1c, CGM, DEXA, sleep tracking, and sustainable changes in food, stress, and training.

How I evaluate drugs for longevity and long term health

How I evaluate drugs for longevity and long term health

A practical framework for deciding which habits and drugs make sense for longevity, using risk benefit analysis, biomarkers, and caution around metformin.

CRISPR in pediatrics: from lab work to real cures today

CRISPR in pediatrics: from lab work to real cures today

A new center aims to speed CRISPR therapies for rare childhood disease. Learn the case of a treated infant and the safety steps involved.

Unapproved peptides: legal and safety risks explained

Unapproved peptides: legal and safety risks explained

Many peptides are marketed like supplements, but they can be unapproved drugs. Understand the rules, product quality, and your risk tolerance.

Testosterone therapy: benefits and side effects to watch

Testosterone therapy: benefits and side effects to watch

If you are considering TRT, understand the long term commitment, how to measure improvements, and which labs and side effects you should track with your doctor.

Discover longevity drugs beyond rapamycin at scale

Discover longevity drugs beyond rapamycin at scale

Why large scale molecule discovery can unlock longevity therapeutics and radiation resilience, and how to evaluate claims with auditable evidence.

How to evaluate longevity drugs without falling for hype

How to evaluate longevity drugs without falling for hype

Metformin, rapamycin, and resveratrol sound promising, but data decides. A practical guide to reading trials, spotting bias, and knowing what not to do.

GLP-1 and longevity: real benefits and clinical limits

GLP-1 and longevity: real benefits and clinical limits

A practical review of GLP-1 use in obesity and cardiometabolic health, including benefits, limits, and risk management.

Heart healthy diet and statins: decide with clarity

Heart healthy diet and statins: decide with clarity

How to combine diet and medication to lower cardiovascular risk, interpret LDL and coronary calcium, and discuss statins without fear or absolutes.

Low dose lithium evidence today for brain longevity

Low dose lithium evidence today for brain longevity

Practical review of low dose lithium, potential brain and aging benefits, current evidence limits, and a safety first framework for clinical decisions.

High blood pressure: measure it and understand it well

High blood pressure: measure it and understand it well

A practical guide to interpret readings, avoid measurement errors, and act early with high impact habits and, when needed, medical care.

Peptides for performance and longevity real risks

Peptides for performance and longevity real risks

What evidence says about popular peptides, regulation, and safety. Learn to separate human outcome data from marketing and choose safer alternatives.

Menopause hormone therapy: realistic benefits and limits

Menopause hormone therapy: realistic benefits and limits

What the WHI taught us and how to decide with clarity about hormone therapy for symptoms and bone health, without headline driven hype.